Table 2 Association of LVD and FVD with clinical and pathological parameters

Catamenia

   Premenopause

68

17.00 ± 1.63

NS

25.97 ± 1.48

NS

   Postmenopause

29

16.33 ± 1.44

25.41 ± 1.83

Tumor size (cm)

   ≤4

61

16.66 ± 1.26

NS

26.32 ± 1.92

NS

   >4

36

17.06 ± 1.22

26.97 ± 1.84

Stromal invasion

   ≤2/3

40

16.29 ± 0.86

NS

25.82 ± 1.66

NS

   >2/3

57

16.69 ± 1.23

26.02 ± 1.70

FIGO stage

   a

16

16.43 ± 1.40

NS*

25.09 ± 1.49

0.032*

   b

33

17.07 ± 1.49

25.21 ± 1.62

   a

48

17.10 ± 1.52

26.10 ± 1.85

Histological grade

   HG₁

21

16.86 ± 1.57

NS*

25.43 ± 1.98

NS*

   HG₂

31

17.15 ± 1.14

26.08 ± 1.75

   HG₃

45

17.24 ± 1.37

25.76 ± 1.37

Lymph node metastasis

   Negative

67

17.15 ± 1.49

0.025

25.70 ± 1.84

NS

   Positive

30

17.93 ± 1.70

26.33 ± 1.82

LVI

   Negative

39

16.49 ± 1.46

0.001

25.97 ± 1.66

NS

   Positive

58

17.66 ± 1.82

26.50 ± 1.74

Histological cell type

   SCC

81

16.76 ± 1.62

NS

25.78 ± 1.64

NS

   ADE

16

17.25 ± 1.26

26.00 ± 1.15